Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury

Bruce H. Dobkin, Armin Curt, James D Guest

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

Background. In China, fetal brain tissue has been transplanted into the lesions of more than 400 patients with spinal cord injury (SCI). Anecdotal reports have been the only basis for assuming that the procedure is safe and effective. Objective. To compare available reports to the experiences and objective findings of patients who received preoperative and postoperative assessments before and up to 1 year after receiving cellular implants. Methods. Independent observational study of 7 chronic SCI subjects undergoing surgery by Dr Hongyun Huang in Beijing. Assessments included lesion location by magnetic resonance imaging, protocol of the American Spinal Injury Association (ASIA), change in disability, and detailed history of the perioperative course. Results. Inclusion and exclusion criteria were not clearly defined, as subjects with myelopathies graded ASIA A through D and of diverse causes were eligible. Cell injection sites did not always correlate with the level of injury and included the frontal lobes of a subject with a high cervical lesion. Complications, including meningitis, occurred in 5 subjects. Transient postoperative hypotonicity may have accounted for some physical changes. No clinically useful sensorimotor, disability, or autonomic improvements were found. Conclusions. The phenotype and the fate of the transplanted cells, described as olfactory ensheathing cells, are unknown. Perioperative morbidity and lack of functional benefit were identified as the most serious clinical shortcomings. The procedures observed did not attempt to meet international standards for either a safety or efficacy trial. In the absence of a valid clinical trials protocol, physicians should not recommend this procedure to patients.

Original languageEnglish
Pages (from-to)5-13
Number of pages9
JournalNeurorehabilitation and Neural Repair
Volume20
Issue number1
DOIs
StatePublished - Mar 1 2006

Fingerprint

Spinal Cord Injuries
Observational Studies
China
Transplants
Clinical Protocols
Spinal Injuries
Spinal Cord Diseases
Frontal Lobe
Meningitis
Fetus
Magnetic Resonance Imaging
Clinical Trials
Morbidity
Physicians
Phenotype
Safety
Injections
Wounds and Injuries
Brain

Keywords

  • Clinical trials
  • Fetal olfactory cells
  • Neural transplantation
  • Neuroplasticity
  • Regeneration
  • Rehabilitation
  • Spinal cord injury

ASJC Scopus subject areas

  • Rehabilitation
  • Clinical Neurology
  • Neuroscience(all)
  • Health Professions(all)

Cite this

Cellular transplants in China : Observational study from the largest human experiment in chronic spinal cord injury. / Dobkin, Bruce H.; Curt, Armin; Guest, James D.

In: Neurorehabilitation and Neural Repair, Vol. 20, No. 1, 01.03.2006, p. 5-13.

Research output: Contribution to journalArticle

@article{9ef99791bf2c4eeeb672e212a4a1e06d,
title = "Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury",
abstract = "Background. In China, fetal brain tissue has been transplanted into the lesions of more than 400 patients with spinal cord injury (SCI). Anecdotal reports have been the only basis for assuming that the procedure is safe and effective. Objective. To compare available reports to the experiences and objective findings of patients who received preoperative and postoperative assessments before and up to 1 year after receiving cellular implants. Methods. Independent observational study of 7 chronic SCI subjects undergoing surgery by Dr Hongyun Huang in Beijing. Assessments included lesion location by magnetic resonance imaging, protocol of the American Spinal Injury Association (ASIA), change in disability, and detailed history of the perioperative course. Results. Inclusion and exclusion criteria were not clearly defined, as subjects with myelopathies graded ASIA A through D and of diverse causes were eligible. Cell injection sites did not always correlate with the level of injury and included the frontal lobes of a subject with a high cervical lesion. Complications, including meningitis, occurred in 5 subjects. Transient postoperative hypotonicity may have accounted for some physical changes. No clinically useful sensorimotor, disability, or autonomic improvements were found. Conclusions. The phenotype and the fate of the transplanted cells, described as olfactory ensheathing cells, are unknown. Perioperative morbidity and lack of functional benefit were identified as the most serious clinical shortcomings. The procedures observed did not attempt to meet international standards for either a safety or efficacy trial. In the absence of a valid clinical trials protocol, physicians should not recommend this procedure to patients.",
keywords = "Clinical trials, Fetal olfactory cells, Neural transplantation, Neuroplasticity, Regeneration, Rehabilitation, Spinal cord injury",
author = "Dobkin, {Bruce H.} and Armin Curt and Guest, {James D}",
year = "2006",
month = "3",
day = "1",
doi = "10.1177/1545968305284675",
language = "English",
volume = "20",
pages = "5--13",
journal = "Journal of Neurologic Rehabilitation",
issn = "1545-9683",
publisher = "Sage Science Press",
number = "1",

}

TY - JOUR

T1 - Cellular transplants in China

T2 - Observational study from the largest human experiment in chronic spinal cord injury

AU - Dobkin, Bruce H.

AU - Curt, Armin

AU - Guest, James D

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Background. In China, fetal brain tissue has been transplanted into the lesions of more than 400 patients with spinal cord injury (SCI). Anecdotal reports have been the only basis for assuming that the procedure is safe and effective. Objective. To compare available reports to the experiences and objective findings of patients who received preoperative and postoperative assessments before and up to 1 year after receiving cellular implants. Methods. Independent observational study of 7 chronic SCI subjects undergoing surgery by Dr Hongyun Huang in Beijing. Assessments included lesion location by magnetic resonance imaging, protocol of the American Spinal Injury Association (ASIA), change in disability, and detailed history of the perioperative course. Results. Inclusion and exclusion criteria were not clearly defined, as subjects with myelopathies graded ASIA A through D and of diverse causes were eligible. Cell injection sites did not always correlate with the level of injury and included the frontal lobes of a subject with a high cervical lesion. Complications, including meningitis, occurred in 5 subjects. Transient postoperative hypotonicity may have accounted for some physical changes. No clinically useful sensorimotor, disability, or autonomic improvements were found. Conclusions. The phenotype and the fate of the transplanted cells, described as olfactory ensheathing cells, are unknown. Perioperative morbidity and lack of functional benefit were identified as the most serious clinical shortcomings. The procedures observed did not attempt to meet international standards for either a safety or efficacy trial. In the absence of a valid clinical trials protocol, physicians should not recommend this procedure to patients.

AB - Background. In China, fetal brain tissue has been transplanted into the lesions of more than 400 patients with spinal cord injury (SCI). Anecdotal reports have been the only basis for assuming that the procedure is safe and effective. Objective. To compare available reports to the experiences and objective findings of patients who received preoperative and postoperative assessments before and up to 1 year after receiving cellular implants. Methods. Independent observational study of 7 chronic SCI subjects undergoing surgery by Dr Hongyun Huang in Beijing. Assessments included lesion location by magnetic resonance imaging, protocol of the American Spinal Injury Association (ASIA), change in disability, and detailed history of the perioperative course. Results. Inclusion and exclusion criteria were not clearly defined, as subjects with myelopathies graded ASIA A through D and of diverse causes were eligible. Cell injection sites did not always correlate with the level of injury and included the frontal lobes of a subject with a high cervical lesion. Complications, including meningitis, occurred in 5 subjects. Transient postoperative hypotonicity may have accounted for some physical changes. No clinically useful sensorimotor, disability, or autonomic improvements were found. Conclusions. The phenotype and the fate of the transplanted cells, described as olfactory ensheathing cells, are unknown. Perioperative morbidity and lack of functional benefit were identified as the most serious clinical shortcomings. The procedures observed did not attempt to meet international standards for either a safety or efficacy trial. In the absence of a valid clinical trials protocol, physicians should not recommend this procedure to patients.

KW - Clinical trials

KW - Fetal olfactory cells

KW - Neural transplantation

KW - Neuroplasticity

KW - Regeneration

KW - Rehabilitation

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=32244446601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32244446601&partnerID=8YFLogxK

U2 - 10.1177/1545968305284675

DO - 10.1177/1545968305284675

M3 - Article

C2 - 16467274

AN - SCOPUS:32244446601

VL - 20

SP - 5

EP - 13

JO - Journal of Neurologic Rehabilitation

JF - Journal of Neurologic Rehabilitation

SN - 1545-9683

IS - 1

ER -